J RHEUMATOL PUBL CO
-
Publisher Of
- The Patient Research Partner Network Matures: A Report from the GRAPPA 2017 Annual Meeting. The Journal of Rheumatology. 45:52-53. 2018
- Open-Label Certolizumab Pegol Is Effective In Patients Who Withdrew From Double-Blind Treatment Due To Non-Response. The Journal of Rheumatology. 1333-1333. 2010
- Safety Update on Certolizumab Pegol (CZP) in Patients with Active Rheumatoid Arthritis (RA). The Journal of Rheumatology. 1332-1332. 2010
- The Efficacy of Certolizumab Pegol Added to Methotrexate is Sustained Over 2 Years in the Treatment of Rheumatoid Arthritis. The Journal of Rheumatology. 1332-1333. 2010
- Certolizumab Pegol Inhibits Radiographic Progression at 16 Weeks of Treatment. Results from Two RCTs (RAPID 1 And 2). The Journal of Rheumatology. 2603-2604. 2009